Our first COVID-19 related monoclonal antibodies are now available: ten antibodies specific to SARS-CoV-2 nucleoprotein and three antibodies specific to Spike (RBD).

Special Offer! Evaluate all these new MAbs 0,5mg free of charge*

Cat.# 3CV4 Monoclonal anti-SARS-CoV-2

Cat.# 3CV2 Monoclonal anti-SARS-CoV-2

Please note that these first antibodies are produced as in vivo products. The same antibodies in recombinant or in vitro formats will be ready in November/December. More clones will become available in the coming weeks as well. 

Additionally we have limited amounts of R&D samples of clones that are not available as commercial products yet: twelve antibodies specific to SARS-CoV-2 nucleoprotein and two specific to Spike (RBD), please inquire below. For a full list of antibodies and preliminary pair recommendations, see the data sheets.

Learn more:

SARS-CoV-2 TechNotes
See all our COVID-19 Products

*Terms: The special offer opportunity is only available to end users. Institutes and universities are not included in this promotion. The usual shipping and handling costs will still apply. The opportunity is a one-time evaluation possibility, feedback about the evaluation results is expected and you can get more details by contacting HyTest customer service at hytest@hytest.fi.